FAP and intestinal polyp: In the case of animal experiments, 5-ASA administrations to Min mice (FAP model mice that have an Apc mutation and develop intestinal polyps) at doses of 500, 2400, 4800, and 9600 parts/million (ppm) failed to show direct chemosuppressive activity against the development of intestinal polyps [12].